Abstract
AbstractA series of metalloproteinase CD163 ectodomain shedding inhibitors based on azasugar hydroxamic acid scaffold has been synthesized. Among the synthesized compounds, the benzyl derivative 4a and the methyl derivative 4f exhibits 66 and 51 % inhibition, respectively, at 1 μM concentration on CD163 shedding from human monocytes. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have